FLT3 and acute myeloid leukemia: The aim of this study was the retrospective analysis of the clinical characteristics and treatment outcomes in children with AML and the FLT3-ITD mutation treated in Poland between 2005, when the analysis of FLT3 became widely available, and 2022.